In 2025, AstraZeneca continues to impress me with the strong performances of its oncology, cardiovascular, and rare disease franchises. So, revenue from Enhertu, which is a highly effective ...

AstraZeneca insists that its COVID-19 vaccine is strongly effective even after counting additional illnesses in its U.S. study, the latest in an extraordinary public dispute with American officials.

AstraZeneca says that its COVID-19 vaccine is strongly effective even after counting additional illnesses in its U.S. study. The announcement late Wednesday was the latest in an extraordinary public ...